Market access of cancer drugs in European countries: improving resource allocation Kim PauwelsIsabelle HuysSteven Simoens Review 19 November 2013 Pages: 95 - 110
The success story of trastuzumab emtansine, a targeted therapy in HER2-positive breast cancer Véronique DiérasThomas Bachelot Review 14 July 2013 Pages: 111 - 122
Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabine Daniela Laura PapademetrioVictoria CavaliereÉlida Álvarez Original Research 16 April 2013 Pages: 123 - 134
Anti-leukemic response of a NSAID, tolfenamic acid Robert M. SutphinSarah F. ConnellyRiyaz Basha Original Research 23 April 2013 Pages: 135 - 144
Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases Johnny KaoChien-Ting ChenMax W. Sung Original Research 10 May 2013 Pages: 145 - 153
Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT M. Di BartolomeoF. Pietrantonioon behalf of Italian Trials in Medical Oncology (ITMO) Group Original Research 03 July 2013 Pages: 155 - 162
A novel system enhancing the endosomal escapes of peptides promotes Bak BH3 peptide inducing apoptosis in lung cancer A549 cells Nanjing LinWenyun ZhengXingyuan Ma Original Research 06 June 2013 Pages: 163 - 170
Is availability of anti-EGFR therapy for the colorectal adenocarcinomas showing fascin expression limited? Nazım Emrah KoçerFazilet Kayaselçuk Original Research 16 April 2013 Pages: 171 - 175
A case of fatal cetuximab-induced interstitial lung disease during the first weeks of treatment Alaaeldin ShablakAndrew Conn Day-to-Day Practice 10 October 2013 Pages: 177 - 180
Erratum to: Recommendations for the clinical and radiological evaluation of response to treatment in metastatic renal cell cancer Luís LeónRoberto García-FigueirasCarmen Sebastiá Erratum 03 May 2014 Pages: 181 - 181
